ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,488Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 151

$635K Total Retail Price of All Prescriptions

Rank: 9 out of 151

496 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,122 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
OMEPRAZOLE 430 287 1 8
LISINOPRIL 387 284 2 11
AMLODIPINE BESYLATE 347 274 3 17
HYDROXYCHLOROQUINE SULFATE 345 246 4 3
METOPROLOL TARTRATE 318 265 5 23
ALENDRONATE SODIUM 316 265 6 10
PRAVASTATIN SODIUM 288 210 7 37
ATENOLOL 281 246 8 15
DICLOFENAC SODIUM 268 149 9 25
SIMVASTATIN 267 199 10 9
METHOTREXATE 253 132 11 2
WARFARIN SODIUM 241 168 12 28
LEVOTHYROXINE SODIUM 222 176 13 18
FUROSEMIDE 214 186 14 20
ALLOPURINOL 190 147 15 5
METFORMIN HCL 186 128 16 26
TRAMADOL HCL 184 132 17 4
ATORVASTATIN CALCIUM 176 160 18 27
PREDNISONE 170 129 19 1
SULINDAC 156 121 20 62
GABAPENTIN 155 76 21 6
NIFEDIPINE ER 137 124 22 91
SERTRALINE HCL 134 112 23 61
NABUMETONE 125 78 24 21
NAPROXEN 124 103 25 36
IBUPROFEN 117 36 26 39
RANITIDINE HCL 115 45 27 49
METOPROLOL SUCCINATE 112 83 28 40
TRAZODONE HCL 108 39 29 38
CRESTOR 106 106 30 50
HYDROCODONE-ACETAMINOPHEN 103 59 S3 31 7
DIOVAN 98 68 32 56
FAMOTIDINE 90 36 33 83
HYDROCHLOROTHIAZIDE 89 65 34 19
LOVASTATIN 82 82 35 109
TAMSULOSIN HCL 82 65 35 68
PANTOPRAZOLE SODIUM 81 72 37 53
NIFEDICAL XL 75 75 38 113
RISPERIDONE 71 45 39 115
LYRICA 70 26 40 31
FLUTICASONE PROPIONATE 70 21 40 80
SPIRIVA 70 66 40 76
AMITRIPTYLINE HCL 67 42 R 43 32
FENOFIBRATE 67 26 43 65
SPIRONOLACTONE 66 53 45 83
CELEBREX 66 61 45 16
CITALOPRAM HBR 65 65 47 42
ACTOS 63 51 48 121
COLCRYS 61 48 49 30
ROPINIROLE HCL 61 45 49 123
DILTIAZEM 24HR ER 59 55 51 74
DOXAZOSIN MESYLATE 58 45 52 128
ETODOLAC 57 19 53 35
HALOPERIDOL 55 11 54 131
DONEPEZIL HCL 54 54 55 72
POTASSIUM CHLORIDE 53 31 56 54
ISOSORBIDE MONONITRATE ER 52 37 57 75
PAROXETINE HCL 51 27 58 85
AZITHROMYCIN 51 41 58 78
ENBREL 51 23 58 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.